Dec 20, 2023Chiesi Global Rare Diseases receives FDA approval for FILSUVEZ® topical gel for the treatment of EBFILSUVEZ topical gel is indicated for the treatment of partial thickness wounds in patients 6 months and older with Junctional and...
May 24, 2023US FDA gives its first approval for new treatment for dystrophic EBKrystal Biotech has received FDA approval for the first-ever redosable gene therapy, VYJUVEKâ„¢.